دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension
Ekkehard Grünig, MD,a Pavel Jansa, MD, PH D, b Fenling Fan, MD, PHD, c Jakob A. Hauser, MD, PH D, d Matthieu Pannaux, MSC ,e Adele Morganti, MS C, f Hany Rofael, MD, PH D, g Kelly M. Chin, MD, MSCS
doi : 10.1016/j.jacc.2023.10.045
Volume 83, Issue 4, 30 January 2024, Pages 473-484
Double Down on Single-Tablet Combination Therapy in Pulmonary Arterial Hypertension: Possible Benefits for Selected Patients∗
Jeroen N. Wessels, MD, Harm Jan Bogaard, MD, P
doi : 10.1016/j.jacc.2023.11.014
Volume 83, Issue 4, 30 January 2024, Pages 485-487
Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients With Functional Mitral Regurgitation
Adnan K. Chhatriwalla, MD, a David J. Cohen, MD, MS C,b,c Sreekanth Vemulapalli, MD, d Andrew Vekstein, MD, d Chetan P. Huded, MD, MSC ,a Dianne Gallup, MS, d Andrzej S. Kosinski, PH D, d Leo Brothers, MPH,d JoAnn Lindenfeld, MD, e Gregg W. Stone, MD,f Paul Sorajja, MD
doi : 10.1016/j.jacc.2023.11.012
Volume 83, Issue 4, 30 January 2024, Pages 488-499
Filling in the Mitral Valve Transcatheter Edge-to-Edge Repair Data Gaps∗
doi : 10.1016/j.jacc.2023.11.016
Volume 83, Issue 4, 30 January 2024, Pages 500-502
Prognostic Implications of Initial Focal Contrast Enhancement in Acute Type B Intramural Hematoma
doi : 10.1016/j.jacc.2023.10.046
Volume 83, Issue 4, 30 January 2024, Pages 503-513
Role of Initial Focal Contrast Enhancement in Type B Intramural Hematoma∗
Konstantinos Spanos, PH D, a,b Tilo K?lbel, PHD
doi : 10.1016/j.jacc.2023.11.017
Volume 83, Issue 4, 30 January 2024, Pages 514-515
Growth of the Neo-Aortic Root and Prognosis of Transposition of the Great Arteries
Aditya Sengupta, MD, MPH, a Chrystalle Katte Carreon, MD, b,c Kimberlee Gauvreau, SC D, d,e Ji M. Lee, BS, a Stephen P. Sanders, MD,b,f Steven D. Colan, MD,e,f Pedro J. del Nido, MD,a,g John E. Mayer, Jr, MD, a,g Meena Nathan, MD, MPH
doi : 10.1016/j.jacc.2023.10.023
Volume 83, Issue 4, 30 January 2024, Pages 516-527
The Neo-Aortic Root After Arterial Switch Operation: Defining the New Normal∗
Michael D. Seckeler, MD, MS
doi : 10.1016/j.jacc.2023.10.024
Volume 83, Issue 4, 30 January 2024, Pages 528-529
Racial and Ethnic Disparities in Perioperative Health Care Among Patients Undergoing Cardiac Surgery: JACC State-of-the-Art Review
Adam J. Milam, MD, PHD, a, * Modele O. Ogunniyi, MD, MPH,b,c, * Abimbola O. Faloye, MD, d Luis R. Castellanos, MD, MPH, e Ricardo E. Verdiner, MD,a James W. Stewart II, MD,f Merije Chukumerije, MD, g Alexis K. Okoh, MD, b Steven Bradley, MD, MS, h Robert O. Roswell, MD,i Paul L. Douglass, MD,j Shakirat O. Oyetunji, MD, MPH,k Alexander Iribarne, MD, MS, l Debra Furr-Holden, P HD, m Harish Ramakrishna, MD,n Sharonne N. Hayes, MD
doi : 10.1016/j.jacc.2023.11.015
Volume 83, Issue 4, 30 January 2024, Pages 530-545
Predictors of Repeated Septal Reduction After Alcohol Septal Ablation in Patients With Hypertrophic Cardiomyopathy
Takashi Hiruma, MD *Mitsunobu Kitamura, MD Itaru Takamisawa, MD Yuki Izumi, MD Ryosuke Higuchi, MD Mamoru Nanasato, MD Tomoki Shimokawa, MD Shuichiro Takanashi, MD Mitsuaki Isobe, MD Morimasa Takayama, MD
doi : 10.1016/j.jacc.2023.11.013
Volume 83, Issue 4, 30 January 2024, Pages 546-548
Drawing Conclusions From Exploratory Analyses: A Slippery Slope
Sanjay Kaul, MD G.B. John Mancini, MD William S. Weintraub, MD Raffaele De Caterina, MD, PhD on behalf of INTEGRITTY
doi : 10.1016/j.jacc.2023.10.050
Volume 83, Issue 4, 30 January 2024, Page e31
And Yet it Moves: E Pur Si Muove
Patrick Myers, MD c Joe Sabik, MDd Faisal Bakeen, MD
doi : 10.1016/j.jacc.2023.10.049
Volume 83, Issue 4, 30 January 2024, Page e33
Functional vs Anatomical Complete Revascularization: Is There an “ISCHEMIA” of FFR?
Kyriakos Dimitriadis, MD, PhD Nikolaos Pyrpyris, MD Konstantinos Tsioufis, MD, PhD
doi : 10.1016/j.jacc.2023.10.048
Volume 83, Issue 4, 30 January 2024, Page e35
Benefit of Complete Anatomic Revascularization in ISCHEMIA: Reprise of a Familiar Theme
Robert A. Guyton, MD Michael E. Halkos, MD, MSc
doi : 10.1016/j.jacc.2023.10.047
Volume 83, Issue 4, 30 January 2024, Page e37
REPLY: Interpreting the Impact of Complete Revascularization in the ISCHEMIA Trial
Gregg W. Stone, MD a Ziad A. Ali, MD, DPhil b,c Judith S. Hochman, MDd David J. Maron, MD
doi : 10.1016/j.jacc.2023.11.018
Volume 83, Issue 4, 30 January 2024, Pages e39-e40
